Please login or register first to view this content.
Psychiatric Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Benzodiazepine Use Linked to Risk for Ectopic Pregnancy
Phase 3 Trial Evaluating Roluperidone in Schizophrenia Misses End Points
Dayvigo Now Available for Insomnia Treatment
Pharmacogenetics in Antidepressant Selection for Major Depressive Disorder
Unapproved Cannabidiol, Curcumin Injectables Marketed for Multiple Disorders Recalled
Review Highlights Neuropsychiatric Presentations of COVID-19
FDA to Review Manipulation-Resistant Stimulant Med for ADHD
Dasotraline Development for ADHD, Binge Eating Disorder Halted, NDAs Withdrawn
Differences in Anxiety, Depression According to Current and Former Smoking Status
Aristada, Vivitrol Access Expanded During COVID-19 Pandemic
Boxed Warning Added to Montelukast Labeling Regarding Neuropsychiatric Events
Clinical Improvement Observed in Narcolepsy Trial Evaluating Once-Nightly Sodium Oxybate Formulation
Daridorexant Improves Sleep, Daytime Performance in Insomnia Study
FDA: Guidance on Digital Therapeutics for Psychiatric Disorders During COVID-19
Novel Agent Promising for the Treatment of Schizophrenia
Secuado Transdermal System Now Available for Schizophrenia
Somryst, A Prescription Digital Therapeutic for Chronic Insomnia, Gets FDA Nod
Lower Sodium Oxybate Formulation Gets Priority Review for Narcolepsy
